Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Billionaire investor Ron Baron is up big on his investments in Tesla and SpaceX and he doesn't plan on selling.
Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target ...
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $710 t...
JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from...
Stephen Weiss of Short Hills Capital Partners recommended buying Meta Platforms, which is down almost 20% from the high.
BTIG analyst Mark Massaro maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and raises the price target from $785 to $830.
